Dermatology , July 2025 Japan Tobacco, Osaka, Japan / LEO Pharma, Ballerup, Denmark In July 2025, delgocitinib (Anzupgo), a topical pan-JAK inhibitor, gained FDA approval for the treatment of CHE (chronic hand eczema) in adults with an inadequate response to topical corticosteroids or for whom corticosteroids are not advisable
Learn about our comprehensive assessment, treatment, and recovery programs or schedule an initial evaluation by contacting our intake team today
From it's inaugural appearance in 1958, the Gibson ES-335 set an unmatched standard
Built for the updated 2026 Ploom EVO range, Purple Option keeps the clean Heat-not-Burn routine customers expect from Ploom, with no smoke, no ash, and a noticeably less lingering smell than cigarettes
And unfortunately, Alex, that has been a very fraudulent idea and information has been withheld from all of us for millennia